Cargando…

Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial

BACKGROUND: At present, effectively implementing smoking cessation programs in the health care system constitutes a major challenge. A unique opportunity to initiate smoking cessation focuses on smokers scheduled for surgery. These patients are not only highly motivated to quit smoking but also like...

Descripción completa

Detalles Bibliográficos
Autores principales: Fankhauser, Christian D., Affentranger, Andres, Cortonesi, Beatrice, Jeker, Urs, Gass, Markus, Minervini, Fabrizio, Jung, Georg, Christmann, Corina, Brambs, Christine, Puhan, Milo A., Held, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422094/
https://www.ncbi.nlm.nih.gov/pubmed/36038883
http://dx.doi.org/10.1186/s13063-022-06628-8
_version_ 1784777740054953984
author Fankhauser, Christian D.
Affentranger, Andres
Cortonesi, Beatrice
Jeker, Urs
Gass, Markus
Minervini, Fabrizio
Jung, Georg
Christmann, Corina
Brambs, Christine
Puhan, Milo A.
Held, Ulrike
author_facet Fankhauser, Christian D.
Affentranger, Andres
Cortonesi, Beatrice
Jeker, Urs
Gass, Markus
Minervini, Fabrizio
Jung, Georg
Christmann, Corina
Brambs, Christine
Puhan, Milo A.
Held, Ulrike
author_sort Fankhauser, Christian D.
collection PubMed
description BACKGROUND: At present, effectively implementing smoking cessation programs in the health care system constitutes a major challenge. A unique opportunity to initiate smoking cessation focuses on smokers scheduled for surgery. These patients are not only highly motivated to quit smoking but also likely to benefit from a reduction in postoperative complications which may translate into a decrease of costs. Nevertheless, surgical patients are not routinely informed about the benefits of preoperative smoking cessation. Potential reasons for this missed opportunity may be the lack of time and training of surgeons and anaesthesiologists. We therefore aim to analyse the impact of a preoperative high-intensity smoking cessation intervention on surgical complications up to a 90-day postoperative period in patients of various surgical disciplines. The hypothesis is that a preoperative smoking cessation program improves outcomes in smokers undergoing intermediate to high-risk surgery. METHODS: The present study is a single-centre, randomized trial with two parallel groups of smokers scheduled for surgery comparing surgery alone and surgery with preoperative smoking cessation. We plan to randomize 251 patients. The primary objective is to compare complications between patients with an institutional multifaceted smoking cessation intervention starting 4 weeks before surgery compared to patients in the advice-only group (control group) within a 90-day postoperative period. The primary endpoint is the Comprehensive Complication Index (CCI®) within 90 days of surgery. Secondary outcomes include the length of hospital stay, cost of care, quality of life, smoking abstinence, and reduction in nicotine consumption. DISCUSSION: The hypothesis is that a preoperative smoking cessation program improves outcomes in smokers undergoing surgery. TRIAL REGISTRATION: BASEC #2021-02004; ClinicalTrials.gov: NCT05192837. Registered on January 14, 2022. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-06628-8.
format Online
Article
Text
id pubmed-9422094
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94220942022-08-30 Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial Fankhauser, Christian D. Affentranger, Andres Cortonesi, Beatrice Jeker, Urs Gass, Markus Minervini, Fabrizio Jung, Georg Christmann, Corina Brambs, Christine Puhan, Milo A. Held, Ulrike Trials Study Protocol BACKGROUND: At present, effectively implementing smoking cessation programs in the health care system constitutes a major challenge. A unique opportunity to initiate smoking cessation focuses on smokers scheduled for surgery. These patients are not only highly motivated to quit smoking but also likely to benefit from a reduction in postoperative complications which may translate into a decrease of costs. Nevertheless, surgical patients are not routinely informed about the benefits of preoperative smoking cessation. Potential reasons for this missed opportunity may be the lack of time and training of surgeons and anaesthesiologists. We therefore aim to analyse the impact of a preoperative high-intensity smoking cessation intervention on surgical complications up to a 90-day postoperative period in patients of various surgical disciplines. The hypothesis is that a preoperative smoking cessation program improves outcomes in smokers undergoing intermediate to high-risk surgery. METHODS: The present study is a single-centre, randomized trial with two parallel groups of smokers scheduled for surgery comparing surgery alone and surgery with preoperative smoking cessation. We plan to randomize 251 patients. The primary objective is to compare complications between patients with an institutional multifaceted smoking cessation intervention starting 4 weeks before surgery compared to patients in the advice-only group (control group) within a 90-day postoperative period. The primary endpoint is the Comprehensive Complication Index (CCI®) within 90 days of surgery. Secondary outcomes include the length of hospital stay, cost of care, quality of life, smoking abstinence, and reduction in nicotine consumption. DISCUSSION: The hypothesis is that a preoperative smoking cessation program improves outcomes in smokers undergoing surgery. TRIAL REGISTRATION: BASEC #2021-02004; ClinicalTrials.gov: NCT05192837. Registered on January 14, 2022. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-06628-8. BioMed Central 2022-08-29 /pmc/articles/PMC9422094/ /pubmed/36038883 http://dx.doi.org/10.1186/s13063-022-06628-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Fankhauser, Christian D.
Affentranger, Andres
Cortonesi, Beatrice
Jeker, Urs
Gass, Markus
Minervini, Fabrizio
Jung, Georg
Christmann, Corina
Brambs, Christine
Puhan, Milo A.
Held, Ulrike
Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial
title Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial
title_full Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial
title_fullStr Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial
title_full_unstemmed Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial
title_short Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial
title_sort preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422094/
https://www.ncbi.nlm.nih.gov/pubmed/36038883
http://dx.doi.org/10.1186/s13063-022-06628-8
work_keys_str_mv AT fankhauserchristiand preoperativesmokingcessationprograminpatientsundergoingintermediatetohighrisksurgeryarandomizedsingleblindedcontrolledsuperioritytrial
AT affentrangerandres preoperativesmokingcessationprograminpatientsundergoingintermediatetohighrisksurgeryarandomizedsingleblindedcontrolledsuperioritytrial
AT cortonesibeatrice preoperativesmokingcessationprograminpatientsundergoingintermediatetohighrisksurgeryarandomizedsingleblindedcontrolledsuperioritytrial
AT jekerurs preoperativesmokingcessationprograminpatientsundergoingintermediatetohighrisksurgeryarandomizedsingleblindedcontrolledsuperioritytrial
AT gassmarkus preoperativesmokingcessationprograminpatientsundergoingintermediatetohighrisksurgeryarandomizedsingleblindedcontrolledsuperioritytrial
AT minervinifabrizio preoperativesmokingcessationprograminpatientsundergoingintermediatetohighrisksurgeryarandomizedsingleblindedcontrolledsuperioritytrial
AT junggeorg preoperativesmokingcessationprograminpatientsundergoingintermediatetohighrisksurgeryarandomizedsingleblindedcontrolledsuperioritytrial
AT christmanncorina preoperativesmokingcessationprograminpatientsundergoingintermediatetohighrisksurgeryarandomizedsingleblindedcontrolledsuperioritytrial
AT brambschristine preoperativesmokingcessationprograminpatientsundergoingintermediatetohighrisksurgeryarandomizedsingleblindedcontrolledsuperioritytrial
AT puhanmiloa preoperativesmokingcessationprograminpatientsundergoingintermediatetohighrisksurgeryarandomizedsingleblindedcontrolledsuperioritytrial
AT heldulrike preoperativesmokingcessationprograminpatientsundergoingintermediatetohighrisksurgeryarandomizedsingleblindedcontrolledsuperioritytrial